Pancreatic cells are more adaptable and possess a greater potential for self-healing than previously assumed For decades, the prevailing wisdom was that beta cells could not regenerate and that their loss in type 1 diabetes (T1D) was irreversible—the reason why people with T1D require insulin injections for life. JDRF-funded research is helping rewrite the textbook […]
What Our Members Are Saying
TypeOneNation has been an amazing resource for me. The range of experienced T1Ds on the site is like no other and the amount of support that each person receives cannot be matched.
TypeOneNation provides an instant online community of Type 1 people who offer support and first-hand tips learned through actual life experience.
TypeOneNation gives those in the DOC a chance to meet other people and discuss things on their minds. Whether a person is looking for friendship, support, or just a place to talk.
Knowledge. Support. Strength.
Connecting the type 1 diabetes community.
Recent Community News
Check out this week’s top five picks from around the TypeOneNation community, and join the conversation with other members and be sure to share it with your friends on Twitter and Facebook too. JDRF News JDRF partners with Beta-O2 Technologies to develop a novel implantable encapsulation device for T1D – [Read More] Cheerleading/Tumbling @AbbisMommy03 asks […]
JDRF takes center stage at Capitol Hill briefing on accelerating biomedical research progress Richard A. Insel, M.D., JDRF’s Chief Scientific Officer, joined other research leaders at a Congressional briefing on, “How the Research-by-Consortia Model Will Lead to Faster Cures” held recently in Washington D.C. The briefing brought together biomedical leaders from foundations, industry, government, and […]
JDRF’s partner ViaCyte recently announced the U.S. Food and Drug Administration (FDA) is allowing them to move forward with a clinical trial of its innovative type 1 diabetes (T1D) encapsulated cell replacement therapy called VC-01™ product candidate. The company plans to immediately initiate the first ever clinical evaluation of a stem cell-derived islet replacement therapy […]